Literature DB >> 11269651

Combinatorial chemistry in cancer drug development.

K A Leonard1, A B Deisseroth, D J Austin.   

Abstract

The field of combinatorial chemistry has grown at an enormous rate in recent years, both in response to high-throughput capabilities and the discovery of a plethora of novel therapeutic targets. This review attempts to outlinethe recent developments of combinatorial chemistry in the search for novel cancer-related therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11269651

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  1 in total

Review 1.  The impact of FDA and EMEA guidelines on drug development in relation to Phase 0 trials.

Authors:  S Marchetti; J H M Schellens
Journal:  Br J Cancer       Date:  2007-08-28       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.